诱导治疗后肺叶切除术:微创入路不损害生存
该研究基于美国国家癌症数据库2010-2014年2887例接受诱导化疗或放化疗后肺叶切除术的NSCLC患者,比较VATS与开胸手术的结局。VATS与更短住院时间相关,30天和90天死亡率无显著差异,5年生存率在全体队列和倾向评分匹配分析中均无显著差异,多变量分析显示VATS与生存无显著关联。
要点
- 诱导治疗后VATS肺叶切除术不增加30天和90天死亡率。
- VATS与更短住院时间相关(中位5天 vs 6天)。
- VATS与开胸手术的5年生存率无显著差异。
核心结论
- 对于接受诱导治疗的局部晚期非小细胞肺癌患者,VATS肺叶切除术与开胸手术相比,短期和长期结局均无显著差异。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库2010-2014年数据,纳入2887例接受诱导化疗或放化疗后肺叶切除术的T2-T4,N0,M0或T1-T4,N1-N2,M0非小细胞肺癌患者。
主要发现
- VATS组676例(23%),开胸组2211例(77%)。
临床怎么用
- 对于接受诱导治疗的局部晚期非小细胞肺癌患者,VATS肺叶切除术可作为开胸手术的可行选择,不损害短期或长期生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study was to evaluate the impact of a video-assisted thoracoscopic (VATS) approach on outcomes in patients who underwent lobectomy after induction therapy. METHODS: Outcomes of patients with T2-T4, N0, M0 and T1-T4, N1-N2, M0 non-small-cell lung cancer who received induction chemotherapy or chemoradiation followed by lobectomy in the National Cancer Data Base (2010-2014) were assessed using Kaplan-Meier, propensity score-matched, multivariable logistic regression and Cox proportional hazards analyses. RESULTS: In the National Cancer Data Base, 2887 lobectomy patients met inclusion criteria (VATS 676 [23%]; thoracotomy 2211 [77%]). Of the VATS cases, patients who underwent induction chemoradiation were more likely to undergo conversion (adjusted odds ratio 1.70, P = .05). Compared with an open approach, VATS was associated with decreased length of stay (median: 5 days vs 6 days, P < .01) and no significant differences in 30-day mortality (VATS [1.5% (n = 10)] vs open [2.6% (n = 58)]; P = .13) and 90-day mortality (VATS [3.7% (n = 25)] vs open [5.6% (n = 124)]; P = .14). There were no significant differences in 5-year survival between the VATS and open groups in both the entire cohort (VATS [50.3%] vs open [52.3%]; P = .83) and in a propensity score-matched analysis of 876 patients; furthermore, a VATS approach was not associated with worse survival in multivariable analysis (hazard ratio 1.02; 95% confidence interval 0.86-1.20; P = .83). CONCLUSIONS: In this national analysis, a VATS approach for lobectomy in patients who received induction therapy for locally advanced non-small-cell lung cancer was not associated with worse short-term or long-term outcomes when compared with an open approach.
引用
- Yang CJ, Nwosu A, Mayne NR, et al. A Minimally Invasive Approach to Lobectomy After Induction Therapy Does Not Compromise Survival. Ann Thorac Surg. 2019. PMID: 31733187. doi:10.1016/j.athoracsur.2019.09.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。